Home / SBMFF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SBMFF make money? Does SBMFF have pricing power? What's the Earnings Whisper? Will SBMFF profit more as the business scales? What is SBMFF's management track record? Is SBMFF's current price justified?

Sino Biopharmaceutical Limited

$0.7 -$0.17 (-19.72%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.7

Day Range

$0.65$0.7

Year Range

$0.59$1.16

Market Cap

12.47B

AVG Volume

270

Trailing/Forward PE

33.74/2.65

PEG ratio

9.58

Dividend Yield

2.29%

Next Earnings Date

2027-04-01

Primary Exchange

Other OTC

Revenue (CNY)

SBMFF Revenue (CNY) by year
Period	Revenue (CNY)
2025	31.83B
2024	28.87B
2023	15.28B
2022	26.03B
2021	26.86B
2020	23.65B
2019	24.23B
2018	20.89B
2017	14.82B
2016	14.17B

Net Income (CNY)

SBMFF Net Income (CNY) by year
Period	Net Income (CNY)
2025	2.34B
2024	3.5B
2023	1.26B
2022	2.06B
2021	14.61B
2020	4.15B
2019	3.3B
2018	9.05B
2017	2.17B
2016	1.71B

Operating Income (CNY)

SBMFF Operating Income (CNY) by year
Period	Operating Income (CNY)
2025	6.95B
2024	5.99B
2023	3.13B
2022	5.39B
2021	4.63B
2020	4.89B
2019	5.81B
2018	4.97B
2017	5.26B
2016	4.71B

EBITDA (CNY)

SBMFF EBITDA (CNY) by year
Period	EBITDA (CNY)
2025	7.26B
2024	6.13B
2023	3.65B
2022	6.25B
2021	13.75B
2020	5.54B
2019	6.36B
2018	4.95B
2017	4.38B
2016	3.59B

Cash Flows (CNY)

SBMFF Cash Flows (CNY) by year
Period	Cash Flows (CNY)
2025	8.05B
2024	2.67B
2023	1.92B
2022	5.02B
2021	1.9B
2020	0
2019	1.8B
2018	2.6B
2017	1.99B
2016	1.65B

EPS (CNY)

SBMFF EPS (CNY) by year
Period	EPS (CNY)
2025	0.13
2024	0.1
2023	0.07
2022	0.11
2021	0.76
2020	0.22
2019	0.18
2018	0.49
2017	0.13
2016	0.1

Expenses (CNY)

SBMFF Expenses (CNY) by year
Period	Expenses (CNY)
2025	20.41B
2024	17.66B
2023	9.56B
2022	17.2B
2021	17.58B
2020	14.26B
2019	15.22B
2018	13.64B
2017	9.66B
2016	8.93B

Cash & Debt (CNY)

SBMFF Cash & Debt (CNY) by year
Period	Cash & Debt (CNY)
2025	22.96B
2024	14.6B
2023	11.01B
2022	16.92B
2021	15.79B
2020	16.43B
2019	19.11B
2018	13.02B
2017	9.9B
2016	8.57B

Debt ratios

SBMFF Debt ratios by year
Period	Debt ratios
2025	-0.3
2024	-0.16
2023	0.05
2022	-0.09
2021	-0.12
2020	-0.1
2019	-0.54
2018	-0.61

Margins

SBMFF Margins by year
Period	Margins
2025	82.07%
2024	81.51%
2023	78.68%
2022	82.76%
2021	80.15%
2020	78.08%
2019	79.67%
2018	79.91%
2017	79.14%
2016	79.2%

Return on Capital

SBMFF Return on Capital by year
Period	Return on Capital
2025	5.57%
2024	8.18%
2023	3.3%
2022	5.43%
2021	38.72%
2020	18.51%
2019	8.18%
2018	24.09%
2017	17.21%
2016	16.03%

Shares Outstanding

SBMFF Shares Outstanding by year
Period	Shares Outstanding
2025	18B
2024	17.24B
2023	18.57B
2022	16.05B
2021	20.52B
2020	18.58B
2019	18.59B
2018	18.36B
2017	14.4B
2016	16.68B

Dividends (CNY)

SBMFF Dividends (CNY) by year
Period	Dividends (CNY)
2026	0.02
2025	0.01
2024	0.01
2023	0.01
2022	0.01
2021	0.01
2020	0.01
2019	0.01
2018	0.01
2017	0

Book Value Per Share (CNY)

SBMFF Book Value Per Share (CNY) by year
Period	Book Value Per Share (CNY)
2025	2.34
2024	2.48
2023	2.06
2022	2.36
2021	1.84
2020	1.21
2019	2.17
2018	2.05
2017	0.88
2016	0.64

Total Assets (CNY)

SBMFF Total Assets (CNY) by year
Period	Total Assets (CNY)
2025	76.01B
2024	65.41B
2023	63.6B
2022	64.06B
2021	60.54B
2020	47.21B
2019	58.3B
2018	49.78B
2017	20.94B
2016	18.39B

PE Ratio

SBMFF PE Ratio by year
Period	PE Ratio
Sep 26	35.81
Sep 26	37.77
Aug 26	38.47
Aug 26	38.46
Aug 26	31.36
Aug 26	31.39
Jul 26	32.8
Jul 26	32.9
Jul 26	32.92
Jul 26	32.92
Jul 26	30.69
Jun 26	31.44
Jun 26	31.28
Jun 26	32.88
Jun 26	32.9
May 26	32.9
May 26	36.12
May 26	36.2
May 26	36.36
May 26	39.86
Apr 26	39.91
Apr 26	39.8
Apr 26	39.81
Apr 26	40.14
Mar 26	30.39
Mar 26	33.11
Mar 26	33.16
Mar 26	33.56
Feb 26	33.37
Feb 26	33.61
Feb 26	33.61
Feb 26	31.27
Jan 26	35.55
Jan 26	35.62
Jan 26	35.97
Jan 26	35.24
Jan 26	35.32
Dec 25	28.44
Dec 25	28.58
Dec 25	28.64
Dec 25	28.7
Nov 25	28.72
Nov 25	28.62
Nov 25	28.59
Nov 25	28.68
Oct 25	28.56
Oct 25	28.58
Oct 25	30.19
Oct 25	32.85
Oct 25	36.13
Sep 25	38.02
Sep 25	39.67
Sep 25	43.2
Sep 25	34.5
Aug 25	34.49
Aug 25	34.65
Aug 25	34.73
Aug 25	32.64
Aug 25	33.61
Jul 25	31.27
Jul 25	32.16
Jul 25	24.96
Jul 25	23.91
Jun 25	24.49
Jun 25	22.47
Jun 25	24.93
Jun 25	19.59
May 25	19.9
May 25	17.51
May 25	17.58
May 25	17.61
May 25	17.7
Apr 25	17.73
Apr 25	16.83
Apr 25	16.31
Apr 25	16.29
Dec 23	39.43
Dec 23	36.33
Dec 23	38.09
Dec 23	46.96
Nov 23	47.03
Nov 23	47.44
Nov 23	41.66
Nov 23	38.03
Oct 23	32.09
Oct 23	32.08
Oct 23	33.3
Oct 23	31.05
Sep 23	32.99
Sep 23	29.01
Sep 23	28.92
Sep 23	29.19
Sep 23	28.86
Aug 23	28.98
Aug 23	32.85
Aug 23	30.71
Aug 23	33.13
Jul 23	34.56
Jul 23	33.28
Jul 23	32.99

Free Cash Flow Yield

SBMFF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	7.8%
Sep 26	7.39%
Aug 26	7.26%
Aug 26	7.26%
Aug 26	8.9%
Aug 26	8.9%
Jul 26	8.51%
Jul 26	8.49%
Jul 26	8.48%
Jul 26	8.48%
Jul 26	9.1%
Jun 26	10.93%
Jun 26	10.99%
Jun 26	10.45%
Jun 26	10.45%
May 26	10.45%
May 26	9.52%
May 26	9.49%
May 26	9.45%
May 26	8.62%
Apr 26	8.61%
Apr 26	8.64%
Apr 26	8.63%
Apr 26	8.56%
Mar 26	5.79%
Mar 26	5.32%
Mar 26	5.31%
Mar 26	5.25%
Feb 26	5.28%
Feb 26	5.24%
Feb 26	5.24%
Feb 26	5.63%
Jan 26	4.95%
Jan 26	4.94%
Jan 26	4.9%
Jan 26	5%
Jan 26	4.98%
Dec 25	2.62%
Dec 25	2.61%
Dec 25	2.61%
Dec 25	2.6%
Nov 25	2.6%
Nov 25	2.61%
Nov 25	2.61%
Nov 25	2.6%
Oct 25	2.61%
Oct 25	2.61%
Oct 25	2.47%
Oct 25	2.27%
Oct 25	2.07%
Sep 25	1.98%
Sep 25	1.9%
Sep 25	1.75%
Sep 25	2.19%
Aug 25	2.19%
Aug 25	2.18%
Aug 25	2.17%
Aug 25	2.31%
Aug 25	2.24%
Jul 25	2.41%
Jul 25	2.35%
Jul 25	3.02%
Jul 25	3.16%
Jun 25	3.12%
Jun 25	3.4%
Jun 25	3.06%
Jun 25	3.9%
May 25	3.84%
May 25	4.36%
May 25	4.34%
May 25	4.33%
May 25	4.31%
Apr 25	4.3%
Apr 25	4.53%
Apr 25	4.68%
Apr 25	4.69%
Dec 23	6.57%
Dec 23	7.13%
Dec 23	6.8%
Dec 23	5.51%
Nov 23	5.51%
Nov 23	5.46%
Nov 23	6.22%
Nov 23	6.81%
Oct 23	8.07%
Oct 23	8.07%
Oct 23	7.78%
Oct 23	8.34%
Sep 23	7.85%
Sep 23	8.62%
Sep 23	8.64%
Sep 23	8.56%
Sep 23	8.66%
Aug 23	8.63%
Aug 23	7.61%
Aug 23	8.14%
Aug 23	7.55%
Jul 23	7.23%
Jul 23	7.51%
Jul 23	7.58%

Price to Sales

SBMFF Price to Sales by year
Period	Price to Sales
Sep 26	2.59
Sep 26	2.73
Aug 26	2.78
Aug 26	2.78
Aug 26	2.26
Aug 26	2.27
Jul 26	2.37
Jul 26	2.38
Jul 26	2.38
Jul 26	2.38
Jul 26	2.22
Jun 26	2.31
Jun 26	2.3
Jun 26	2.42
Jun 26	2.42
May 26	2.42
May 26	2.66
May 26	2.66
May 26	2.68
May 26	2.93
Apr 26	2.94
Apr 26	2.93
Apr 26	2.93
Apr 26	2.96
Mar 26	3.03
Mar 26	3.3
Mar 26	3.3
Mar 26	3.34
Feb 26	3.32
Feb 26	3.35
Feb 26	3.35
Feb 26	3.11
Jan 26	3.54
Jan 26	3.55
Jan 26	3.58
Jan 26	3.51
Jan 26	3.52
Dec 25	3.6
Dec 25	3.62
Dec 25	3.63
Dec 25	3.64
Nov 25	3.64
Nov 25	3.62
Nov 25	3.62
Nov 25	3.63
Oct 25	3.62
Oct 25	3.62
Oct 25	3.82
Oct 25	4.16
Oct 25	4.58
Sep 25	4.72
Sep 25	4.92
Sep 25	5.36
Sep 25	4.28
Aug 25	4.28
Aug 25	4.3
Aug 25	4.31
Aug 25	4.05
Aug 25	4.17
Jul 25	3.88
Jul 25	3.99
Jul 25	3.1
Jul 25	2.97
Jun 25	2.97
Jun 25	2.72
Jun 25	3.02
Jun 25	2.37
May 25	2.41
May 25	2.12
May 25	2.13
May 25	2.14
May 25	2.15
Apr 25	2.15
Apr 25	2.04
Apr 25	1.98
Apr 25	1.97
Dec 23	2.11
Dec 23	1.94
Dec 23	2.04
Dec 23	2.51
Nov 23	2.52
Nov 23	2.54
Nov 23	2.23
Nov 23	2.03
Oct 23	1.72
Oct 23	1.72
Oct 23	1.78
Oct 23	1.66
Sep 23	1.77
Sep 23	1.92
Sep 23	1.92
Sep 23	1.93
Sep 23	1.91
Aug 23	1.92
Aug 23	2.18
Aug 23	2.04
Aug 23	2.2
Jul 23	2.29
Jul 23	2.21
Jul 23	2.19

EV/EBITDA

SBMFF EV/EBITDA by year
Period	EV/EBITDA
Sep 26	9.85
Sep 26	10.38
Aug 26	10.57
Aug 26	10.56
Aug 26	8.66
Aug 26	8.67
Jul 26	9.05
Jul 26	9.07
Jul 26	9.08
Jul 26	9.08
Jul 26	8.48
Jun 26	9.2
Jun 26	9.15
Jun 26	9.67
Jun 26	9.68
May 26	9.68
May 26	10.72
May 26	10.74
May 26	10.79
May 26	11.92
Apr 26	11.94
Apr 26	11.9
Apr 26	11.91
Apr 26	12.02
Mar 26	14.65
Mar 26	15.92
Mar 26	15.94
Mar 26	16.13
Feb 26	16.04
Feb 26	16.15
Feb 26	16.15
Feb 26	15.06
Jan 26	17.06
Jan 26	17.08
Jan 26	17.25
Jan 26	16.91
Jan 26	16.95
Dec 25	15.3
Dec 25	15.39
Dec 25	15.42
Dec 25	15.46
Nov 25	15.48
Nov 25	15.41
Nov 25	15.39
Nov 25	15.45
Oct 25	15.37
Oct 25	15.38
Oct 25	16.41
Oct 25	18.09
Oct 25	20.16
Sep 25	21.61
Sep 25	22.6
Sep 25	24.73
Sep 25	19.49
Aug 25	19.48
Aug 25	19.59
Aug 25	19.63
Aug 25	18.37
Aug 25	18.96
Jul 25	17.55
Jul 25	18.08
Jul 25	13.75
Jul 25	13.11
Jun 25	13.21
Jun 25	12.05
Jun 25	13.46
Jun 25	10.4
May 25	10.58
May 25	9.22
May 25	9.26
May 25	9.28
May 25	9.33
Apr 25	9.35
Apr 25	8.83
Apr 25	8.53
Apr 25	8.52
Dec 23	8
Dec 23	7.32
Dec 23	7.71
Dec 23	9.66
Nov 23	9.67
Nov 23	9.76
Nov 23	8.49
Nov 23	7.69
Oct 23	6.39
Oct 23	6.39
Oct 23	6.66
Oct 23	6.16
Sep 23	6.59
Sep 23	7.91
Sep 23	7.88
Sep 23	7.96
Sep 23	7.87
Aug 23	7.9
Aug 23	8.96
Aug 23	8.37
Aug 23	9.04
Jul 23	9.43
Jul 23	9.08
Jul 23	9

Price/Operating Cashflow

SBMFF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	10.99
Sep 26	11.59
Aug 26	11.81
Aug 26	11.8
Aug 26	9.62
Aug 26	9.63
Jul 26	10.06
Jul 26	10.1
Jul 26	10.1
Jul 26	10.1
Jul 26	9.42
Jun 26	7.93
Jun 26	7.89
Jun 26	8.29
Jun 26	8.3
May 26	8.3
May 26	9.11
May 26	9.13
May 26	9.17
May 26	10.05
Apr 26	10.06
Apr 26	10.04
Apr 26	10.04
Apr 26	10.12
Mar 26	15.17
Mar 26	16.52
Mar 26	16.55
Mar 26	16.75
Feb 26	16.65
Feb 26	16.78
Feb 26	16.78
Feb 26	15.61
Jan 26	17.74
Jan 26	17.78
Jan 26	17.95
Jan 26	17.59
Jan 26	17.63
Dec 25	34.84
Dec 25	35.01
Dec 25	35.08
Dec 25	35.16
Nov 25	35.18
Nov 25	35.06
Nov 25	35.02
Nov 25	35.13
Oct 25	34.98
Oct 25	35.01
Oct 25	36.98
Oct 25	40.24
Oct 25	44.25
Sep 25	44.92
Sep 25	46.86
Sep 25	51.04
Sep 25	40.76
Aug 25	40.74
Aug 25	40.94
Aug 25	41.04
Aug 25	38.56
Aug 25	39.71
Jul 25	36.94
Jul 25	37.99
Jul 25	29.49
Jul 25	28.25
Jun 25	27.84
Jun 25	25.54
Jun 25	28.34
Jun 25	22.27
May 25	22.62
May 25	19.91
May 25	19.99
May 25	20.02
May 25	20.12
Apr 25	20.16
Apr 25	19.13
Apr 25	18.54
Apr 25	18.52
Dec 23	11.04
Dec 23	10.17
Dec 23	10.67
Dec 23	13.15
Nov 23	13.17
Nov 23	13.29
Nov 23	11.67
Nov 23	10.65
Oct 23	8.99
Oct 23	8.99
Oct 23	9.33
Oct 23	8.7
Sep 23	9.24
Sep 23	8.91
Sep 23	8.88
Sep 23	8.96
Sep 23	8.86
Aug 23	8.9
Aug 23	10.09
Aug 23	9.43
Aug 23	10.17
Jul 23	10.62
Jul 23	10.22
Jul 23	10.13

Price to Book

SBMFF Price to Book by year
Period	Price to Book
Sep 26	1.83
Sep 26	1.93
Aug 26	1.97
Aug 26	1.97
Aug 26	1.6
Aug 26	1.61
Jul 26	1.68
Jul 26	1.68
Jul 26	1.68
Jul 26	1.68
Jul 26	1.57
Jun 26	1.75
Jun 26	1.74
Jun 26	1.83
Jun 26	1.83
May 26	1.83
May 26	2.01
May 26	2.02
May 26	2.02
May 26	2.22
Apr 26	2.22
Apr 26	2.22
Apr 26	2.22
Apr 26	2.24
Mar 26	2.24
Mar 26	2.44
Mar 26	2.45
Mar 26	2.48
Feb 26	2.46
Feb 26	2.48
Feb 26	2.48
Feb 26	2.31
Jan 26	2.63
Jan 26	2.63
Jan 26	2.66
Jan 26	2.6
Jan 26	2.61
Dec 25	2.41
Dec 25	2.42
Dec 25	2.42
Dec 25	2.43
Nov 25	2.43
Nov 25	2.42
Nov 25	2.42
Nov 25	2.43
Oct 25	2.42
Oct 25	2.42
Oct 25	2.55
Oct 25	2.78
Oct 25	3.06
Sep 25	3.06
Sep 25	3.19
Sep 25	3.48
Sep 25	2.78
Aug 25	2.78
Aug 25	2.79
Aug 25	2.8
Aug 25	2.63
Aug 25	2.71
Jul 25	2.52
Jul 25	2.59
Jul 25	2.01
Jul 25	1.92
Jun 25	2
Jun 25	1.84
Jun 25	2.04
Jun 25	1.6
May 25	1.63
May 25	1.43
May 25	1.44
May 25	1.44
May 25	1.45
Apr 25	1.45
Apr 25	1.38
Apr 25	1.33
Apr 25	1.33
Mar 25	1.33
Mar 25	1.24
Mar 25	1.24
Mar 25	1.24
Feb 25	1.24
Feb 25	1.24
Feb 25	1.08
Feb 25	1.09
Jan 25	1.09
Jan 25	1.2
Jan 25	1.21
Jan 25	1.21
Jan 25	1.21
Dec 24	1.45
Dec 24	1.45
Dec 24	1.49
Dec 24	1.47
Nov 24	1.46
Nov 24	1.48
Nov 24	1.5
Nov 24	1.49
Nov 24	1.62
Oct 24	1.62
Oct 24	1.61

No video analysis for this stock yet. Request one from our team.

News: SBMFF

reuters.com · 8 Jul 2026

Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs

Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China unit had secured rights to ‌market two respiratory drugs from British company GSK in mainland China.

wsj.com · 7 Jul 2026

AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal

Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.

reuters.com · 7 Jul 2026

Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion

Hong Kong-listed Sino Biopharmaceutical said on Wednesday it has granted AstraZeneca the ‌rights to develop a drug designed to treat chronic respiratory diseases outside China for total payments of up to $1.9 ⁠billion.